European Biotech Acquisition - Warrants (06/03/2026) Net Tangible Assets

As of the most recent data (December 2022), EBACW shows a net tangible assets of $120M. That compares with $-6.7M in the prior-year period — up 1912.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBACW's net tangible assets is now $120M (was $-6.7M) — a 1912.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition - Warrants (06/03/2026) is outperforming or lagging.

Tracking EBACW's net tangible assets over time shows whether European Biotech Acquisition - Warrants (06/03/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $120M That compares with $-6.7M in the prior-year period — up 1912.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has European Biotech Acquisition - Warrants (06/03/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $120M) with ownership activity and broader fundamentals.